In Europe, liver cirrhosis represents the fourth-most common cause of death, being responsible for 170,000 deaths and 5500 liver transplantations per year. The main driver of its decompensation is portal hypertension, whose progression radically changes the prognosis of affected patients. Transjugular intrahepatic portosystemic shunt (TIPS) is one of the main therapeutic strategies for these patients as it reverts portal hypertension, thus improving survival. However, the coexistence of portal hypertension and pulmonary hypertension or heart failure is considered a contraindication to TIPS. Nevertheless, in the latest guidelines, the definition of heart failure has not been specified. It is unclear whether the contraindication concerns the presence of clinical signs and symptoms of heart failure or hemodynamic changes in the right heart-pulmonary circulation. Moreover, data about induced right heart volume overload after TIPS and the potential development of heart failure and pulmonary hypertension is currently scanty and controversial. In this article we revise this issue in finding predictors of cardiac performance after TIPS procedure. Performing a fluid challenge during right heart catheterization might be a promising expedient to test the adaptation of the right ventricle to a sudden increase in preload in the first few months after TIPS. This test may unmask a potential cardiac inability to sustain the hemodynamic load after TIPS, allowing for a clearer definition of heart failure and, consequently, a more robust indication to TIPS.

Hemodynamic evaluation of the right heart-pulmonary circulation unit in patients candidate to transjugular intrahepatic portosystemic shunt / Manguso, G.; Vignone, A.; Merli, M.; Miotti, C.; Caputo, A.; Vizza, C. D.; Badagliacca, R.. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 11:2(2022). [10.3390/jcm11020461]

Hemodynamic evaluation of the right heart-pulmonary circulation unit in patients candidate to transjugular intrahepatic portosystemic shunt

Manguso G.
;
Vignone A.;Merli M.;Miotti C.;Caputo A.;Vizza C. D.;Badagliacca R.
2022

Abstract

In Europe, liver cirrhosis represents the fourth-most common cause of death, being responsible for 170,000 deaths and 5500 liver transplantations per year. The main driver of its decompensation is portal hypertension, whose progression radically changes the prognosis of affected patients. Transjugular intrahepatic portosystemic shunt (TIPS) is one of the main therapeutic strategies for these patients as it reverts portal hypertension, thus improving survival. However, the coexistence of portal hypertension and pulmonary hypertension or heart failure is considered a contraindication to TIPS. Nevertheless, in the latest guidelines, the definition of heart failure has not been specified. It is unclear whether the contraindication concerns the presence of clinical signs and symptoms of heart failure or hemodynamic changes in the right heart-pulmonary circulation. Moreover, data about induced right heart volume overload after TIPS and the potential development of heart failure and pulmonary hypertension is currently scanty and controversial. In this article we revise this issue in finding predictors of cardiac performance after TIPS procedure. Performing a fluid challenge during right heart catheterization might be a promising expedient to test the adaptation of the right ventricle to a sudden increase in preload in the first few months after TIPS. This test may unmask a potential cardiac inability to sustain the hemodynamic load after TIPS, allowing for a clearer definition of heart failure and, consequently, a more robust indication to TIPS.
2022
fluid challenge; heart failure; portal hypertension; pulmonary hypertension; right heart catheterization; transjugular intrahepatic portosystemic shunt
01 Pubblicazione su rivista::01a Articolo in rivista
Hemodynamic evaluation of the right heart-pulmonary circulation unit in patients candidate to transjugular intrahepatic portosystemic shunt / Manguso, G.; Vignone, A.; Merli, M.; Miotti, C.; Caputo, A.; Vizza, C. D.; Badagliacca, R.. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 11:2(2022). [10.3390/jcm11020461]
File allegati a questo prodotto
File Dimensione Formato  
Manguso_Hemodynamic_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 227.96 kB
Formato Adobe PDF
227.96 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1626900
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact